000 01762 a2200565 4500
005 20250514191701.0
264 0 _c20040622
008 200406s 0 0 eng d
022 _a0950-2688
024 7 _a10.1017/s0950268804001979
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHavelaar, A H
245 0 0 _aDisease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157.
_h[electronic resource]
260 _bEpidemiology and infection
_cJun 2004
300 _a467-84 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCost of Illness
650 0 4 _aPersons with Disabilities
650 0 4 _aEpidemiologic Studies
650 0 4 _aEscherichia coli Infections
_xmortality
650 0 4 _aEscherichia coli O157
_xpathogenicity
650 0 4 _aFemale
650 0 4 _aHemolytic-Uremic Syndrome
_xmortality
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aKidney Failure, Chronic
_xetiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Theoretical
650 0 4 _aMortality
650 0 4 _aNetherlands
_xepidemiology
650 0 4 _aQuality-Adjusted Life Years
650 0 4 _aShiga Toxin
700 1 _aVan Duynhoven, Y T
700 1 _aNauta, M J
700 1 _aBouwknegt, M
700 1 _aHeuvelink, A E
700 1 _aDe Wit, G A
700 1 _aNieuwenhuizen, M G
700 1 _avan de Kar, N C
773 0 _tEpidemiology and infection
_gvol. 132
_gno. 3
_gp. 467-84
856 4 0 _uhttps://doi.org/10.1017/s0950268804001979
_zAvailable from publisher's website
999 _c14895561
_d14895561